help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MIGNON, A.
Right arrow Articles by JOULIN, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MIGNON, A.
Right arrow Articles by JOULIN, V.

Am. J. Respir. Crit. Care Med., Volume 159, Number 4, April 1999, 1308-1315

LPS Challenge in D-galactosamine-Sensitized Mice Accounts for Caspase-dependent Fulminant Hepatitis, not for Septic Shock

ALEXANDRE MIGNON, NICOLAS ROUQUET, MONIQUE FABRE, SYLVIE MARTIN, JEAN CHRISTOPHE PAGÈS, JEAN FRANÇOIS DHAINAUT, AXEL KAHN, PASCALE BRIAND, and VIRGINIE JOULIN

INSERM U 129 ICGM; INSERM U 380 ICGM; Service d'Anatomopathologie, Hopital du Kremlin-Bicêtre; INSERM U 294, Faculté Xavier Bichat; and Service de Réanimation, Hopital Cochin, Paris, France

Experimental models of sepsis using endotoxin challenges, including studies with sensitized animals with D-galactosamine, have largely contributed to the basic rationale for innovative clinical trials in human septic shock, which have, to date, failed. The ability of these models to reproduce human disease has been highly discussed. We report here that the widely used D-galactosamine/LPS model does not account for septic shock. Treatment with YVAD-CMK, a potent tetrapeptide inhibitor of caspases of the interleukin (IL)-1beta converting enzyme (ICE) family, protects from LPS-induced liver apoptosis and mortality in D-galactosamine-sensitized mice when administered either before or up to 2 h after the lethal challenge. This curative effect is related to complete inhibition of caspase-3 activity in the liver. However, YVAD-CMK does not affect LPS-induced release of IL-1beta and does not protect from a lethal dose of LPS in unsensitized mice. These experiments demonstrate the difference between these two widely recognized experimental models of sepsis. LPS toxicity in D-galactosamine-treated mice, leading to blocked gene transcription, results from tumor necrosis factor (TNF)-alpha -induced caspase-3-dependent liver injury, not from the systemic inflammatory response. These results provide evidence that inhibitors of the ICE caspase family can prevent or even overcome the ongoing hepatic injury induced by TNF-alpha during sepsis, ischemia-reperfusion, or severe hepatitis.




This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
I. Vanlaere and C. Libert
Matrix Metalloproteinases as Drug Targets in Infections Caused by Gram-Negative Bacteria and in Septic Shock
Clin. Microbiol. Rev., April 1, 2009; 22(2): 224 - 239.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. Faulkner, D. M. Altmann, S. Ellmerich, I. Huhtaniemi, G. Stamp, and S. Sriskandan
Sexual Dimorphism in Superantigen Shock Involves Elevated TNF-{alpha} and TNF-{alpha} induced Hepatic Apoptosis
Am. J. Respir. Crit. Care Med., September 1, 2007; 176(5): 473 - 482.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
A-H. Kwon, Z. Qiu, K. Tsuji, T. Miyaso, and T. Okumura
Fibronectin Prevents Endotoxin Shock After Partial Hepatectomy in Rats via Inhibition of Nuclear Factor-{kappa}B and Apoptosis
Experimental Biology and Medicine, July 1, 2007; 232(7): 895 - 903.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Latta, G. Kunstle, R. Lucas, H. Hentze, and A. Wendel
ATP-Depleting Carbohydrates Prevent Tumor Necrosis Factor Receptor 1-Dependent Apoptotic and Necrotic Liver Injury in Mice
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 875 - 883.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
D. Motzkus, S. Schulz-Maronde, A. Heitland, A. Schulz, W.-G. Forssmann, M. Jubner, and E. Maronde
The novel {beta}-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo
FASEB J, August 1, 2006; 20(10): 1701 - 1702.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
A. Macagno, M. Molteni, A. Rinaldi, F. Bertoni, A. Lanzavecchia, C. Rossetti, and F. Sallusto
A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression
J. Exp. Med., June 12, 2006; 203(6): 1481 - 1492.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
W. Jiang, R. Sun, H. Wei, and Z. Tian
Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages
PNAS, November 22, 2005; 102(47): 17077 - 17082.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. O. Yarovinsky, M. P. Mohning, M. A. Bradford, M. M. Monick, and G. W. Hunninghake
Increased Sensitivity to Staphylococcal Enterotoxin B following Adenoviral Infection
Infect. Immun., June 1, 2005; 73(6): 3375 - 3384.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
C. Oberholzer, A. Oberholzer, S. K. Tschoeke, R. M. Minter, F. R. Bahjat, D. LaFace, B. Hutchins, and L. L. Moldawer
Influence of recombinant adenovirus on liver injury in endotoxicosis and its modulation by IL-10 expression
Innate Immunity, December 1, 2004; 10(6): 393 - 401.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
D. Liu, C. Li, Y. Chen, C. Burnett, X. Y. Liu, S. Downs, R. D. Collins, and J. Hawiger
Nuclear Import of Proinflammatory Transcription Factors Is Required for Massive Liver Apoptosis Induced by Bacterial Lipopolysaccharide
J. Biol. Chem., November 12, 2004; 279(46): 48434 - 48442.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. C. Hoglen, L.-S. Chen, C. D. Fisher, B. P. Hirakawa, T. Groessl, and P. C. Contreras
Characterization of IDN-6556 (3-{2-(2-tert-Butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic Acid): a Liver-Targeted Caspase Inhibitor
J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 634 - 640.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. O. Yarovinsky, L. S. Powers, N. S. Butler, M. A. Bradford, M. M. Monick, and G. W. Hunninghake
Adenoviral Infection Decreases Mortality from Lipopolysaccharide-Induced Liver Failure Via Induction of TNF-{alpha} Tolerance
J. Immunol., September 1, 2003; 171(5): 2453 - 2460.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. L. Copple, F. Moulin, U. M. Hanumegowda, P. E. Ganey, and R. A. Roth
Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused Livers
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 417 - 425.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
E. Jirillo, D. Caccavo, T. Magrone, E. Piccigallo, L. Amati, A. Lembo, C. Kalis, and M. Gumenscheimer
Review: The role of the liver in the response to LPS: experimental and clinical findings
Innate Immunity, October 1, 2002; 8(5): 319 - 327.
[Abstract] [PDF]

Home page
 Innate ImmunityHome page
R. Hasunuma, H. Maruyama, H. Takimoto, R. Ryll, S. Tanaka, and Y. Kumazawa
Does high mobility group 1 protein function as a late mediator for LPS- or TNF-induced shock in galactosamine-sensitized mice?
Innate Immunity, October 1, 2002; 8(5): 391 - 398.
[Abstract] [PDF]

Home page
 Innate ImmunityHome page
A. Oberholzer, C. Oberholzer, F.R. Bahjat, C. K. Edwards, and L. L. Moldawer
Genetic determinants of lipopolysaccharide and D-galactosamine-mediated hepatocellular apoptosis and lethality
Innate Immunity, October 1, 2001; 7(5): 375 - 380.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
C. Guillot, H. Coathalem, J. Chetritt, A. David, P. Lowenstein, E. Gilbert, L. Tesson, N. van Rooijen, M. C. Cuturi, J.-P. Soulillou, et al.
Lethal Hepatitis After Gene Transfer of IL-4 in the Liver Is Independent of Immune Responses and Dependent on Apoptosis of Hepatocytes: A Rodent Model of IL-4-Induced Hepatitis
J. Immunol., April 15, 2001; 166(8): 5225 - 5235.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
C. OBERHOLZER, A. OBERHOLZER, M. CLARE-SALZLER, and L. L. MOLDAWER
Apoptosis in sepsis: a new target for therapeutic exploration
FASEB J, April 1, 2001; 15(6): 879 - 892.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. Fauvel, P. Marchetti, C. Chopin, P. Formstecher, and R. Neviere
Differential effects of caspase inhibitors on endotoxin-induced myocardial dysfunction and heart apoptosis
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1608 - H1614.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. R. Bahjat, V. R. Dharnidharka, K. Fukuzuka, L. Morel, J. M. Crawford, M. J. Clare-Salzler, and L. L. Moldawer
Reduced Susceptibility of Nonobese Diabetic Mice to TNF-{alpha} and D-Galactosamine-Mediated Hepatocellular Apoptosis and Lethality
J. Immunol., December 1, 2000; 165(11): 6559 - 6567.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Kawasaki, K. Kuwano, N. Hagimoto, T. Matsuba, R. Kunitake, T. Tanaka, T. Maeyama, and N. Hara
Protection from Lethal Apoptosis in Lipopolysaccharide-Induced Acute Lung Injury in Mice by a Caspase Inhibitor
Am. J. Pathol., August 1, 2000; 157(2): 597 - 603.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
H. Hentze, F. Gantner, S. A. Kolb, and A. Wendel
Depletion of Hepatic Glutathione Prevents Death Receptor-Dependent Apoptotic and Necrotic Liver Injury in Mice
Am. J. Pathol., June 1, 2000; 156(6): 2045 - 2056.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. D. Josephs, F. R. Bahjat, K. Fukuzuka, R. Ksontini, C. C. Solorzano, C. K. Edwards III, C. L. Tannahill, S. L. D. MacKay, E. M. Copeland III, and L. L. Moldawer
Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2000; 278(5): R1196 - R1201.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-G. Kwon, J.-K. Min, K.-M. Kim, D.-J. Lee, T. R. Billiar, and Y.-M. Kim
Sphingosine 1-Phosphate Protects Human Umbilical Vein Endothelial Cells from Serum-deprived Apoptosis by Nitric Oxide Production
J. Biol. Chem., March 30, 2001; 276(14): 10627 - 10633.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society 		  Red In Translatin